Quality key factors
Factor
Value
Sales Growth (5y)
39.75%
EBIT Growth (5y)
-184.75%
EBIT to Interest (avg)
-5.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.24
Sales to Capital Employed (avg)
0.39
Tax Ratio
19.86%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
22.26
EV to EBIT
-19.96
EV to EBITDA
-21.90
EV to Capital Employed
24.02
EV to Sales
27.76
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-120.36%
ROE (Latest)
-84.95%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
No Trend
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for ABIONYX Pharma SA
Debtors Turnover Ratio
Highest at 1.9%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -19.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for ABIONYX Pharma SA
Inventory Turnover Ratio
Lowest at 17.72% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Operating Profit
Lowest at EUR -2.71 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (EUR MM)
Net Profit
Lowest at EUR -2.29 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (EUR MM)
Net Profit
Fallen at -80.55%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (EUR MM)






